%PDF-1.4
%
4 0 obj
<>
endobj
5 0 obj
<>stream
Hubatsch M.; Peters R.; Maxeiner A.; El-Bandar N.; Weinberger S.; Friedersdorff F.
Nephron Sparing Surgery in Renal Allograft in Recipients with de novo Renal Cell Carcinoma: Two Case Reports and Review of the Literature
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.<br />
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.<br />
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
We report 2 cases of de novo renal cell carcinoma (RCC) in renal grafts after transplantation. Both patients underwent nephron sparing surgery (NSS) 211 and 167 months after transplantation, revealing papillary RCC with a tumour size >4 cm (pT1a). Within a follow-up of 25 and 32 months after NSS, a stable renal function without indication for dialysis was present. No recurrence of RCC in both cases was reported within the yearly routine examinations. NSS in kidney allografts is a safe procedure with preservation of renal function.
Renal cell carcinoma
Kidney transplantation
Posttransplant malignancy
Nephron sparing surgery
endstream
endobj
6 0 obj
<>stream
x+ |
endstream
endobj
7 0 obj
<>stream
x}
0<uh6fѡX#(.As9Y[à $r!Ԟ#}Ux
)A82YjB&0UǷS,}Cޙls]o07@ʶ??\2=猣 L|#oHfA
endstream
endobj
8 0 obj
<>stream
x+ |
endstream
endobj
9 0 obj
<>stream
x}
0<uhڛ4fѡX#(.As9Y[àI N]IR
P{/sTH ɲ4U5:m~"Fg|-ygxiYwC_L*۾21c)JA%=vLx GJ A
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
x}
0<uhڛ&fѡZ#(.As9Y[͡I N"rL Ԟ#ā!nRpd.mEYT6W?Lp-<ش\^oBtiij۾21cRʐ2>r현>stream
HWMs6WQ` A27m:餝6QOvCĖ$9NLPۏS v*wk|A9M[8m^?zHE
40bgDMkVb '5䈩1!CdtY E)nnXọnz^pqnd]ҕ8